Basal Cell Nevus Syndrome and Sporadic Basal Cell Carcinoma: A Comparative Study of Clinicopathological Features
DOI:
https://doi.org/10.2340/actadv.v105.40692Keywords:
Basal cell carcinoma, Basal cell nevus syndrome, Gorlin syndrome, Odontogenic keratocyst, Pitting, PTCH1Abstract
Basal cell nevus syndrome is caused by mutations in the Sonic hedgehog pathway and characterized by early-onset basal cell carcinoma. The features of basal cell carcinoma in basal cell nevus syndrome compared with sporadic basal cell carcinoma have not been explored. This study is a retrospective study of patients with basal cell nevus syndrome in two medical centres in Taiwan from 1991 to 2021 and patients with sporadic basal cell carcinoma excised from 2015 to 2020. An analysis of 18 patients with basal cell nevus syndrome showed an older mean age at the first diagnosis of basal cell carcinoma (37.5 years) than reported in Western countries. The majority of basal cell carcinomas were located in the head and neck region (80.7%), with nodular BCC being the most common tumour type (47.0%). Compared with sporadic basal cell carcinomas, basal cell carcinomas in basal cell nevus syndrome patients occurred more frequently on the scalp (34.7% vs 6.1%, p < 0.001). In addition, the superficial type of basal cell carcinoma was more likely to be seen in basal cell nevus syndrome (24.7% vs 10.4%, p < 0.001). The limitations were that some features of the basal cell nevus syndrome patients might not have been present yet at the time of examination or they did not receive thorough screening. In conclusion, the distinct features of basal cell carcinomas in basal cell nevus syndrome patients have important implications for the prevention, diagnosis, and management of basal cell carcinoma in basal cell nevus syndrome patients.
Downloads
References
Gorlin RJ, Goltz RW. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib: a syndrome. N Engl J Med 1960; 262: 908–912.
https://doi.org/10.1056/NEJM196005052621803 DOI: https://doi.org/10.1056/NEJM196005052621803
Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis2008; 3: 32.
https://doi.org/10.1186/1750-1172-3-32 DOI: https://doi.org/10.1186/1750-1172-3-32
Bree AF, Shah MR. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet Part A 2011; 155a: 2091–2097.
https://doi.org/10.1002/ajmg.a.34128 DOI: https://doi.org/10.1002/ajmg.a.34128
Evans DG, Ladusans EJ, Rimmer S, Burnell LD, Thakker N, Farndon PA. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet 1993; 30: 460–464.
https://doi.org/10.1136/jmg.30.6.460 DOI: https://doi.org/10.1136/jmg.30.6.460
Shanley S, Ratcliffe J, Hockey A, Haan E, Oley C, Ravine D, et al. Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet 1994; 50: 282–290.
https://doi.org/10.1002/ajmg.1320500312 DOI: https://doi.org/10.1002/ajmg.1320500312
Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997; 69: 299–308. DOI: https://doi.org/10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.3.CO;2-#
https://doi.org/10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M DOI: https://doi.org/10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M
Ahn SG, Lim YS, Kim DK, Kim SG, Lee SH, Yoon JH. Nevoid basal cell carcinoma syndrome: a retrospective analysis of 33 affected Korean individuals. Int J Oral Maxillofac Surg 2004; 33: 458–462.
https://doi.org/10.1016/j.ijom.2003.11.001 DOI: https://doi.org/10.1016/j.ijom.2003.11.001
Endo M, Fujii K, Sugita K, Saito K, Kohno Y, Miyashita T. Nationwide survey of nevoid basal cell carcinoma syndrome in Japan revealing the low frequency of basal cell carcinoma. Am J Med Genet Part A 2012; 158a: 351–357.
https://doi.org/10.1002/ajmg.a.34421 DOI: https://doi.org/10.1002/ajmg.a.34421
Göppner D, Leverkus M. Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease. J Skin Cancer 2011; 2011: 650258.
https://doi.org/10.1155/2011/650258 DOI: https://doi.org/10.1155/2011/650258
Onodera S, Nakamura Y, Azuma T. Gorlin syndrome: recent advances in genetic testing and molecular and cellular biological research. Int J Mol Sci 2020; 21.
https://doi.org/10.3390/ijms21207559 DOI: https://doi.org/10.3390/ijms21207559
Jones EA, Sajid MI, Shenton A, Evans DG. Basal cell carcinomas in Gorlin syndrome: a review of 202 patients. J Skin Cancer 2011; 2011: 217378.
https://doi.org/10.1155/2011/217378 DOI: https://doi.org/10.1155/2011/217378
Verkouteren BJA, Cosgun B, Reinders M, Kessler P, Vermeulen RJ, Klaassens M, et al. A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome). Br J Dermatol 2022; 186: 215–226.
https://doi.org/10.1111/bjd.20700 DOI: https://doi.org/10.1111/bjd.20700
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297–1303.
https://doi.org/10.1101/gr.107524.110 DOI: https://doi.org/10.1101/gr.107524.110
Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164.
https://doi.org/10.1093/nar/gkq603 DOI: https://doi.org/10.1093/nar/gkq603
Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021; 23: 1381–1390.
https://doi.org/10.1038/s41436-021-01172-3 DOI: https://doi.org/10.1038/s41436-021-01172-3
Hsu S-W, Lin C-Y, Wang C-W, Chung W-H, Yang C-H, Chang-Y. Novel patched 1 mutations in patients with Gorlin-Goltz syndrome strategic treated by smoothened inhibitor. Ann Dermatol 2018; 30: 597–601.
https://doi.org/10.5021/ad.2018.30.5.597 DOI: https://doi.org/10.5021/ad.2018.30.5.597
Rehefeldt-Erne S, Nägeli MC, Winterton N, Felderer L, Weibel L, Hafner J, et al. Nevoid basal cell carcinoma syndrome: report from the Zurich Nevoid Basal Cell Carcinoma Syndrome Cohort. Dermatology (Basel, Switzerland) 2016; 232: 285–292.
https://doi.org/10.1159/000444792 DOI: https://doi.org/10.1159/000444792
Moore MG, Bennett RG. Basal cell carcinoma in Asians: a retrospective analysis of ten patients. J Skin Cancer 2012; 2012: 741397.
https://doi.org/10.1155/2012/741397 DOI: https://doi.org/10.1155/2012/741397
Kimonis VE, Mehta SG, Digiovanna JJ, Bale SJ, Pastakia B. Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or Gorlin) syndrome. Genet Med 2004; 6: 495–502.
https://doi.org/10.1097/01.GIM.0000145045.17711.1C DOI: https://doi.org/10.1097/01.GIM.0000145045.17711.1C
Amlashi SF, Riffaud L, Brassier G, Morandi X. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer 2003; 98: 618–624.
https://doi.org/10.1002/cncr.11537 DOI: https://doi.org/10.1002/cncr.11537
Evans DG, Oudit D, Smith MJ, Rutkowski D, Allan E, Newman WG, et al. First evidence of genotype-phenotype correlations in Gorlin syndrome. J Med Genet 2017; 54: 530–536.
https://doi.org/10.1136/jmedgenet-2017-104669 DOI: https://doi.org/10.1136/jmedgenet-2017-104669
Ikehata H, Ono T. The mechanisms of UV mutagenesis. Journal of radiation research 2011; 52: 115-125.
https://doi.org/10.1269/jrr.10175 DOI: https://doi.org/10.1269/jrr.10175
Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 2004; 6: 530-539.
https://doi.org/10.1097/01.GIM.0000144188.15902.C4 DOI: https://doi.org/10.1097/01.GIM.0000144188.15902.C4
Verkouteren JAC, Pardo LM, Uitterlinden AG, Nijsten T. Non-genetic and genetic predictors of a superficial first basal cell carcinoma. J Eur Acad Dermatol Venereol 2019; 33: 533–540.
https://doi.org/10.1111/jdv.15389 DOI: https://doi.org/10.1111/jdv.15389
Thorsness SL, Freites-Martinez A, Marchetti MA, Navarrete-Dechent C, Lacouture ME, Tonorezos ES. Nonmelanoma Skin cancer in childhood and young adult cancer survivors previously treated with radiotherapy. JNCCN 2019; 17: 237–243.
https://doi.org/10.6004/jnccn.2018.7096 DOI: https://doi.org/10.6004/jnccn.2018.7096
Nishigori C, Arima Y, Matsumura Y, Matsui M, Miyachi Y. Impaired removal of 8-hydroxydeoxyguanosine induced by UVB radiation in naevoid basal cell carcinoma syndrome cells. Br J Dermatol 2005; 153 Suppl 2: 52–56.
https://doi.org/10.1111/j.1365-2133.2005.06970.x DOI: https://doi.org/10.1111/j.1365-2133.2005.06970.x
Applegate LA, Goldberg LH, Ley RD, Ananthaswamy HN. Hypersensitivity of skin fibroblasts from basal cell nevus syndrome patients to killing by ultraviolet B but not by ultraviolet C radiation. Cancer Res 1990; 50: 637–641.
Kim B, Kim MJ, Hur K, Jo SJ, Ko JM, Park SS, et al. Clinical
and genetic profiling of nevoid basal cell carcinoma syndrome in Korean patients by whole-exome sequencing. Sci Rep 2021; 11: 1163.
https://doi.org/10.1038/s41598-020-80867-0 DOI: https://doi.org/10.1038/s41598-020-80867-0
Smith MJ, Beetz C, Williams SG, Bhaskar SS, O’Sullivan J, Anderson B, et al. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. J Clin Oncol 2014; 32: 4155–4161.
https://doi.org/10.1200/JCO.2014.58.2569 DOI: https://doi.org/10.1200/JCO.2014.58.2569
Kato C, Fujii K, Arai Y, Hatsuse H, Nagao K, Takayama Y, et al. Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene. Fam Cancer 2017; 16: 131–138.
https://doi.org/10.1007/s10689-016-9924-2 DOI: https://doi.org/10.1007/s10689-016-9924-2
Matsudate Y, Naruto T, Hayashi Y, Minami M, Tohyama M, Yokota K, et al. Targeted exome sequencing and chromosomal microarray for the molecular diagnosis of nevoid basal cell carcinoma syndrome. J Dermatol Sci 2017; 86: 206–211.
https://doi.org/10.1016/j.jdermsci.2017.02.282 DOI: https://doi.org/10.1016/j.jdermsci.2017.02.282
Morita K, Naruto T, Tanimoto K, Yasukawa C, Oikawa Y, Masuda K, et al. Simultaneous detection of both single nucleotide variations and copy number alterations by next-generation sequencing in Gorlin syndrome. PloS One 2015; 10: e0140480.
https://doi.org/10.1371/journal.pone.0140480 DOI: https://doi.org/10.1371/journal.pone.0140480
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Ching-Ya Wang, Chun-Bing Chen, Franchesca Marie D. Ilagan, Jing-Yi Lin, Wen-Yi Sung, Lai-Ying Lu, Jau-Yu Liau, Yu-Hsiu Chen, Yi-Hua Liao, Jau-Shiuh Chen, Yi-Shuan Sheen, Yao-Yu Chang, Jin-Bon Hong
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
